Posted in | News

Saint Gobain to Buy Maxit Group Mortar Manufacturer from HeidelbergCement

HeidelbergCement announces that it has entered into an agreement with Compagnie de Saint Gobain on the sale of maxit Group. The purchase price amounts to EUR 2,125 million. The closing is subject to regulatory approval and HeidelbergCement expects the transaction to close in late 2007.

With the sale of maxit HeidelbergCement pursues consequently its strategy of focusing on processing and refining of raw materials for its core products cement and aggregates and further downstream activities.

HeidelbergCement will use the transaction proceeds to help finance its acquisition of the British building materials producer Hanson PLC announced earlier this year.

Goldman Sachs acted as financial advisor to HeidelbergCement for the maxit transaction.

Dr. Bernd Scheifele, CEO of HeidelbergCement explained: “With the acquisition of Hanson, in particular, we have re-oriented our business strategy. maxit Group is a profitable and innovative company, but its broad spectrum of products and customers no longer fits with the new direction of HeidelbergCement. We are pleased to have found a buyer in Saint Gobain that will be better able to contribute to the continued growth of maxit.”

maxit Group is the leading producer of dry mortar in Europe and expanded clay products worldwide. In 2006, maxit achieved record earnings as a result of restructuring, especially in Germany, and a favourable market environment internationally. The company employs a staff of 5,130 and is present in 30 countries. In 2006 turnover totalled approximately EUR 1.2 billion and operating income before depreciation reached EUR 179 million.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.